Randomized Phase III Trial Comparing ABVD + Radiotherapy and the Stanford V Regimen In Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the US Intergroup Trial E2496

MLA

Randy D. Gascoyne, et al. “Randomized Phase III Trial Comparing ABVD + Radiotherapy and the Stanford V Regimen In Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the US Intergroup Trial E2496.” Blood, vol. 116, Nov. 2010, p. 416. EBSCOhost, https://doi.org/10.1182/blood.v116.21.416.416.

APA

Randy D. Gascoyne, Bruce D. Cheson, Henry N. Wagner, Nancy L. Bartlett, Brad S. Kahl, Douglas A. Stewart, Fangxin Hong, Joseph Tuscano, Thomas M. Habermann, Ranjana H. Advani, Richard I. Fisher, Jonathan W. Friedberg, Kristie A. Blum, Patrick J. Stiff, Sandra J. Horning, Sue Robinson, Richard T. Hoppe, & Leo I. Gordon. (2010). Randomized Phase III Trial Comparing ABVD + Radiotherapy and the Stanford V Regimen In Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the US Intergroup Trial E2496. Blood, 116, 416. https://doi.org/10.1182/blood.v116.21.416.416

Chicago

Randy D. Gascoyne, Bruce D. Cheson, Henry N. Wagner, Nancy L. Bartlett, Brad S. Kahl, Douglas A. Stewart, Fangxin Hong, et al. 2010. “Randomized Phase III Trial Comparing ABVD + Radiotherapy and the Stanford V Regimen In Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the US Intergroup Trial E2496.” Blood 116 (November): 416. doi:10.1182/blood.v116.21.416.416.